Literature DB >> 25897597

Should patients stop taking aspirin for primary prevention?

Jeremiah P Depta1, Deepak L Bhatt2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25897597     DOI: 10.3949/ccjm.82a.14114

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  3 in total

Review 1.  Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach.

Authors:  Sagar Dugani; Jeffrey M Ames; JoAnn E Manson; Samia Mora
Journal:  Curr Atheroscler Rep       Date:  2018-02-21       Impact factor: 5.113

Review 2.  Management of Coronary Artery Calcium and Coronary CTA Findings.

Authors:  Dustin M Thomas; Sanjay Divakaran; Todd C Villines; Khurram Nasir; Nishant R Shah; Ahmad M Slim; Ron Blankstein; Michael K Cheezum
Journal:  Curr Cardiovasc Imaging Rep       Date:  2015

3.  Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?

Authors:  Jean Jacques N Noubiap; Jobert Richie N Nansseu
Journal:  Vasc Health Risk Manag       Date:  2015-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.